A kind of separation and purification method of dalbavancin
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHANGSHU NANOMICRO BIOTECHNOLOGY CO LTD
- Publication Date
- 2018-09-25
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicine purification, in particular to a method for efficiently separating and purifying dalbavancin. Background technique
[0002] Dalbavancin (Dalbavancin) is a new type of semi-synthetic glycopeptide antibiotics. Its mechanism of action is the same as that of vancomycin and teicoplanin. It can be widely used as a drug for the treatment of skin and soft tissue infections by inhibiting the biosynthesis of the cell wall of G+ bacteria. drug. Dalbavancin has unique pharmacokinetic properties, long half-life, can be administered at weekly intervals, and can be completely metabolized. At present, dalbavancin has achieved good results in the treatment of catheter-related blood-borne infections and skin and soft tissue infections. It has excellent antibacterial activity and safety in vivo, and is an ideal second-generation glycopeptide antibiotic.
[0003] Dalbavancin consists of structurally similar A 0 、A 1 , B ...